Menu

All News

6942 Results

April events focus on campus connections with environment

Surgery can be highly cost-effective care in the developing world

Stanford’s Mark Davis talks on immunology

Researchers have found promising effects of a first-in-class targeted cancer drug called BIND-014 in treating solid tumors